Ignite Creation Date:
2025-12-25 @ 2:25 AM
Ignite Modification Date:
2025-12-28 @ 12:04 AM
Study NCT ID:
NCT03892434
Status:
UNKNOWN
Last Update Posted:
2019-03-27
First Post:
2019-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO
Sponsor:
Yeungnam University College of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
YUMC 2019-02-018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None